Hodgkin lymphoma (HL) is one of the most difficult neoplasms in terms of cytopathological research owing to the lack of established cytological murine models. Although HL is believed to be of lymphoid germinal center B-cell origin, HL cells exhibit unique biphenotypic characteristics of B cells and macrophages. B-cell/macrophage biphenotypic cells have also been identified in the spleen of Lyn-deficient mice. Moreover, Lyn-targeting germinal center-associated nuclear protein (GANP)-transgenic mice ( mice) spontaneously develop a lymphoid tumor. We aimed to investigate whether the lymphoid tumor developed in mice exhibit biphenotypic characteristics of B cells/macrophages that correspond to human HL. Here, we demonstrated GANP overexpression in human HL cells and found that it may regulate transdifferentiation between B cells and macrophages. We also demonstrated that tumors were comparable with B-cell/macrophage biphenotypic Hodgkinoid lymphomas. The tumor cells expressed macrophage-related F4/80, CD68, and CD204 as well as cytoplasmic B220 and µ-/κ-chains; in addition, these cells exhibited phagocytic activity. These cells also expressed transcripts of ; ; and the cytokines monocyte chemoattractant protein (MCP)-1, MCP-5, RANTES, tumor necrosis factor-α and thrombopoietin associated with macrophages as well as granulocyte/macrophage colony-stimulating factor, interleukin (IL)-4, IL-10, IL-12, and IL-13. - mice represent a novel cytological model for the study of cytopathological etiology and oncogenesis of HL.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017268PMC
http://dx.doi.org/10.3390/cancers12010204DOI Listing

Publication Analysis

Top Keywords

b-cell/macrophage biphenotypic
12
novel cytological
8
cytological model
8
hodgkin lymphoma
8
cells
8
biphenotypic characteristics
8
cells macrophages
8
lymphoid tumor
8
cells expressed
8
mice
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!